首页 > 最新文献

Annals of Clinical Microbiology and Antimicrobials最新文献

英文 中文
Chronic endometritis and the endometrial microbiota: implications for reproductive success in patients with recurrent implantation failure. 慢性子宫内膜炎与子宫内膜微生物群:对反复植入失败患者生殖成功的影响。
IF 5.7 2区 医学 Q1 MICROBIOLOGY Pub Date : 2024-05-30 DOI: 10.1186/s12941-024-00710-6
Hong Zhang, Heng Zou, Chanyu Zhang, Shen Zhang

Background: Chronic endometritis (CE) is associated with poor reproductive outcomes, yet the role of endometrial microbiota in patients with recurrent implantation failure (RIF) and CE remains unclear. This study aims to characterize endometrial microbiota in RIF patients with CE and assess its implications for reproductive outcomes.

Methods: In this prospective study, we enrolled RIF patients both with and without CE. Endometrial and cervical samples were collected for 16 S rRNA gene sequencing. Microbiota composition was compared between groups using diversity indices, phylum, and genus-level analysis. Canonical correlation analysis (CCA) and Spearman's correlation coefficients were used to assess relationships between CE, reproductive outcomes, and microbiota. Predictive functional profiling was performed to evaluate metabolic pathways associated with CE.

Results: Endometrial microbiota in CE patients exhibited greater diversity and evenness compared to non-CE patients. Principal coordinates analysis (PCoA) revealed distinct clustering between CE and non-CE groups. Linear discriminant analysis (LDA) identified Proteobacteria, Aminicenantales, and Chloroflexaceae as characteristic of CE, while Lactobacillus, Acinetobacter, Herbaspirillum, Ralstonia, Shewanela, and Micrococcaceae were associated with non-CE. CCA demonstrated associations between CE, adverse reproductive outcomes, and specific bacterial taxa. Microbial metabolic pathways significantly differed between CE and non-CE groups, with enrichment in pathways related to cofactors, vitamins, secondary metabolites, and the immune system in CE patients.

Conclusion: RIF patients with CE exhibit distinct endometrial microbiota compositions associated with adverse reproductive outcomes. The increased microbial diversity and altered metabolic pathways in CE suggest a potential correlation with reproductive outcomes, although further studies are necessary to elucidate the causal relationship between microbiota alterations and fertility. Modulating the endometrial microbiome may represent a novel therapeutic strategy to improve IVF outcomes in patients with CE.

背景:慢性子宫内膜炎(CE)与不良生殖结局相关,但子宫内膜微生物群在复发性种植失败(RIF)和CE患者中的作用仍不清楚。本研究旨在描述RIF合并CE患者子宫内膜微生物群的特征,并评估其对生殖结局的影响:在这项前瞻性研究中,我们招募了有和没有 CE 的 RIF 患者。收集子宫内膜和宫颈样本,进行 16 S rRNA 基因测序。使用多样性指数、门和属级分析比较不同组间的微生物群组成。采用典型相关分析(CCA)和斯皮尔曼相关系数评估 CE、生殖结果和微生物群之间的关系。预测性功能分析用于评估与 CE 相关的代谢途径:结果:与非 CE 患者相比,CE 患者的子宫内膜微生物群表现出更高的多样性和均匀性。主坐标分析(PCoA)显示 CE 组和非 CE 组之间存在明显的聚类。线性判别分析(LDA)发现,变形杆菌、氨基链球菌和绿藻科(Chloroflexaceae)是 CE 的特征,而乳酸杆菌、醋酸杆菌、草吸菌、Ralstonia、Shewanela 和微球菌科(Micrococcaceae)则与非 CE 相关。CCA显示了CE、不良生殖结果和特定细菌类群之间的关联。CE组和非CE组之间的微生物代谢途径存在显著差异,CE患者与辅因子、维生素、次级代谢产物和免疫系统有关的途径更为丰富:结论:患有 CE 的 RIF 患者表现出与不良生殖结局相关的独特子宫内膜微生物群组成。子宫内膜异位症患者体内微生物多样性的增加和代谢途径的改变表明,这可能与生殖结果有关,但要阐明微生物群改变与生育能力之间的因果关系,还需要进一步的研究。调节子宫内膜微生物群可能是改善 CE 患者试管受精结果的一种新型治疗策略。
{"title":"Chronic endometritis and the endometrial microbiota: implications for reproductive success in patients with recurrent implantation failure.","authors":"Hong Zhang, Heng Zou, Chanyu Zhang, Shen Zhang","doi":"10.1186/s12941-024-00710-6","DOIUrl":"10.1186/s12941-024-00710-6","url":null,"abstract":"<p><strong>Background: </strong>Chronic endometritis (CE) is associated with poor reproductive outcomes, yet the role of endometrial microbiota in patients with recurrent implantation failure (RIF) and CE remains unclear. This study aims to characterize endometrial microbiota in RIF patients with CE and assess its implications for reproductive outcomes.</p><p><strong>Methods: </strong>In this prospective study, we enrolled RIF patients both with and without CE. Endometrial and cervical samples were collected for 16 S rRNA gene sequencing. Microbiota composition was compared between groups using diversity indices, phylum, and genus-level analysis. Canonical correlation analysis (CCA) and Spearman's correlation coefficients were used to assess relationships between CE, reproductive outcomes, and microbiota. Predictive functional profiling was performed to evaluate metabolic pathways associated with CE.</p><p><strong>Results: </strong>Endometrial microbiota in CE patients exhibited greater diversity and evenness compared to non-CE patients. Principal coordinates analysis (PCoA) revealed distinct clustering between CE and non-CE groups. Linear discriminant analysis (LDA) identified Proteobacteria, Aminicenantales, and Chloroflexaceae as characteristic of CE, while Lactobacillus, Acinetobacter, Herbaspirillum, Ralstonia, Shewanela, and Micrococcaceae were associated with non-CE. CCA demonstrated associations between CE, adverse reproductive outcomes, and specific bacterial taxa. Microbial metabolic pathways significantly differed between CE and non-CE groups, with enrichment in pathways related to cofactors, vitamins, secondary metabolites, and the immune system in CE patients.</p><p><strong>Conclusion: </strong>RIF patients with CE exhibit distinct endometrial microbiota compositions associated with adverse reproductive outcomes. The increased microbial diversity and altered metabolic pathways in CE suggest a potential correlation with reproductive outcomes, although further studies are necessary to elucidate the causal relationship between microbiota alterations and fertility. Modulating the endometrial microbiome may represent a novel therapeutic strategy to improve IVF outcomes in patients with CE.</p>","PeriodicalId":8052,"journal":{"name":"Annals of Clinical Microbiology and Antimicrobials","volume":"23 1","pages":"49"},"PeriodicalIF":5.7,"publicationDate":"2024-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11140900/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141178689","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Potential antivirulence activity of sub-inhibitory concentrations of ciprofloxacin against Proteus mirabilis isolates: an in-vitro and in-vivo study. 亚抑制浓度环丙沙星对奇异变形杆菌分离株的潜在抗病毒活性:体外和体内研究。
IF 5.7 2区 医学 Q1 MICROBIOLOGY Pub Date : 2024-05-27 DOI: 10.1186/s12941-024-00704-4
Mohamed A Elhosseini, Tarek E El-Banna, Fatma I Sonbol, Maisra M El-Bouseary

Background: Proteus mirabilis is a significant nosocomial pathogen that is frequently associated with a wide range of infections, necessitating heightened attention to mitigate potential health risks. Hence, this study was performed to investigate the impact of sub-minimum inhibitory concentrations (MICs) of ciprofloxacin (CIP) on Proteus mirabilis clinical isolates.

Methods: The sub-MICs of CIP were selected using the growth curve approach. The untreated and treated isolates with sub-MICs of CIP were assessed for their biofilm development, motilities on agar, and other virulence factors. The cell morphology of untreated and treated isolates with sub-MIC of CIP was explored using electron microscope. Moreover, the expression levels of the virulence genes in isolates were measured using quantitative real-time PCR.

Results: Data revealed that sub-MICs of CIP significantly (p < 0.05), in a concentration-dependent manner, inhibited biofilm formation and other virulence factors in the selected isolates. Electron microscope analysis showed cell enlargement and various abnormalities in the cell wall and membrane integrity.

Conclusion: Sub-MICs of CIP exhibited inhibition of virulence and alterations in morphological integrity against P. mirabilis isolates.

背景:奇异变形杆菌是一种重要的院内病原体,经常与多种感染有关,因此有必要加强关注以降低潜在的健康风险。因此,本研究调查了环丙沙星(CIP)次最低抑菌浓度(MIC)对奇异变形杆菌临床分离株的影响:方法:采用生长曲线法选择 CIP 的亚最低抑菌浓度。方法:采用生长曲线法筛选出 CIP 亚 MICs,并对未处理和处理过的 CIP 亚 MICs 分离物进行生物膜发育、琼脂上的运动和其他毒力因子评估。使用电子显微镜观察了未经处理和经处理的亚微克 CIP 分离物的细胞形态。此外,还利用实时定量 PCR 技术测定了分离物中毒力基因的表达水平:结果:数据显示,CIP 的亚 MIC 显著(P结果:数据显示,CIP 亚微粒对 mirabilis 分离物的毒力和形态完整性的改变具有抑制作用。
{"title":"Potential antivirulence activity of sub-inhibitory concentrations of ciprofloxacin against Proteus mirabilis isolates: an in-vitro and in-vivo study.","authors":"Mohamed A Elhosseini, Tarek E El-Banna, Fatma I Sonbol, Maisra M El-Bouseary","doi":"10.1186/s12941-024-00704-4","DOIUrl":"10.1186/s12941-024-00704-4","url":null,"abstract":"<p><strong>Background: </strong>Proteus mirabilis is a significant nosocomial pathogen that is frequently associated with a wide range of infections, necessitating heightened attention to mitigate potential health risks. Hence, this study was performed to investigate the impact of sub-minimum inhibitory concentrations (MICs) of ciprofloxacin (CIP) on Proteus mirabilis clinical isolates.</p><p><strong>Methods: </strong>The sub-MICs of CIP were selected using the growth curve approach. The untreated and treated isolates with sub-MICs of CIP were assessed for their biofilm development, motilities on agar, and other virulence factors. The cell morphology of untreated and treated isolates with sub-MIC of CIP was explored using electron microscope. Moreover, the expression levels of the virulence genes in isolates were measured using quantitative real-time PCR.</p><p><strong>Results: </strong>Data revealed that sub-MICs of CIP significantly (p < 0.05), in a concentration-dependent manner, inhibited biofilm formation and other virulence factors in the selected isolates. Electron microscope analysis showed cell enlargement and various abnormalities in the cell wall and membrane integrity.</p><p><strong>Conclusion: </strong>Sub-MICs of CIP exhibited inhibition of virulence and alterations in morphological integrity against P. mirabilis isolates.</p>","PeriodicalId":8052,"journal":{"name":"Annals of Clinical Microbiology and Antimicrobials","volume":"23 1","pages":"48"},"PeriodicalIF":5.7,"publicationDate":"2024-05-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11131287/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141157861","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of testing methods assessing the in vitro efficacy of the combination of aztreonam with avibactam on multidrug-resistant Gram-negative bacilli 评估阿曲霉素与阿维菌素复方制剂对耐多药革兰氏阴性杆菌体外疗效的测试方法比较
IF 5.7 2区 医学 Q1 MICROBIOLOGY Pub Date : 2024-05-25 DOI: 10.1186/s12941-024-00708-0
Corentin Deckers, Florian Bélik, Olivier Denis, Pierre Bogaerts, Isabel Montesinos, Catherine Berhin, Warda Bouchahrouf, Martin Hoebeke, Stephanie Evrard, Nicolas Gilliard, Merve Okur, Te-Din Huang
Aztreonam-avibactam (ATM-AVI) combination shows promising effectiveness on most carbapenemase-producing Gram-negatives, yet standardized antibiotic susceptibility testing (AST) methods for evaluating the combination in clinical laboratories is lacking. We aimed to evaluate different ATM-AVI AST approaches. 96 characterized carbapenem-resistant clinical isolates belonging to 9 Enterobacterales (EB; n = 80) and P. aeruginosa (PA; n = 16) species, including 90 carbapenemase producers and 72 strains resistant to both CAZ-AVI and ATM, were tested. Paper disk elution (DE; Bio-Rad) and E-test gradient strips stacking (SS; bioMérieux) were performed for the ATM + CAZ-AVI combination. MIC Test Strip (MTS; Liofilchem) was evaluated for ATM-AVI MIC determination. Results were interpreted applying ATM clinical breakpoints of the EUCAST guidelines and compared to the broth microdilution method (Sensititre, Thermofisher). According to broth microdilution method, 93% of EB and 69% of PA were tested susceptible to ATM-AVI. The synergistic effect of ATM-AVI was of 95% for EB, but of only 17% for PA. The MTS method yielded higher categorical and essential agreement (CA/EA) rates for both EB (89%/91%) and PA (94%/94%) compared to SS, where the rates were 87%/83% for EB and 81%/81% for PA. MTS and SS yielded 2 and 3 major discrepancies, respectively, while 3 very major discrepancies each were observed for both methods. Concerning the DE method, CA reached 91% for EB and 81% for PA, but high number of very major discrepancies were observed for EB (n = 6; 8%) and for PA (n = 3; 19%). The ATM-AVI association displayed excellent in vitro activity against highly resistant clinical Enterobacterales strains. MTS method offers accurate ATM-AVI AST results, while the SS method might serve as better alternative then DE method in assessing the efficacy of ATM + CAZ-AVI combination. However, further investigation is needed to confirm the methods' ability to detect ATM-AVI resistance.
阿奇霉素-阿维菌素(ATM-AVI)组合对大多数产碳青霉烯酶的革兰氏阴性菌有很好的疗效,但临床实验室缺乏评估该组合的标准化抗生素药敏试验(AST)方法。我们旨在评估不同的 ATM-AVI AST 方法。我们对 96 株特征化的耐碳青霉烯类临床分离株进行了测试,这些分离株属于 9 种肠杆菌属(EB;n = 80)和铜绿假单胞菌属(PA;n = 16),其中包括 90 株碳青霉烯酶产生株和 72 株对 CAZ-AVI 和 ATM 均耐药的菌株。对 ATM + CAZ-AVI 组合进行了纸盘洗脱(DE;Bio-Rad)和 E 测试梯度条堆叠(SS;生物梅里埃)。MIC测试带(MTS;Liofilchem)用于测定ATM-AVI的MIC。检测结果根据欧盟 CAST 指南的 ATM 临床断点进行解释,并与肉汤微量稀释法(Sensititre,Thermofisher)进行比较。根据肉汤微稀释法,93% 的 EB 和 69% 的 PA 对 ATM-AVI 易感。ATM-AVI 对 EB 的增效作用为 95%,但对 PA 的增效作用仅为 17%。与 SS 相比,MTS 方法对 EB(89%/91%)和 PA(94%/94%)的分类和基本一致率(CA/EA)更高,EB 为 87%/83%,PA 为 81%/81%。MTS 和 SS 分别产生了 2 次和 3 次重大差异,而两种方法各出现了 3 次非常重大的差异。在 DE 方法中,EB 的 CA 达到 91%,PA 达到 81%,但 EB(n = 6;8%)和 PA(n = 3;19%)出现了大量的极不一致。ATM-AVI 联合物对高耐药性临床肠杆菌菌株具有出色的体外活性。MTS 法可提供准确的 ATM-AVI AST 结果,而 SS 法在评估 ATM + CAZ-AVI 组合的疗效方面可能比 DE 法更好。不过,要确认这些方法检测 ATM-AVI 耐药性的能力,还需要进一步的研究。
{"title":"Comparison of testing methods assessing the in vitro efficacy of the combination of aztreonam with avibactam on multidrug-resistant Gram-negative bacilli","authors":"Corentin Deckers, Florian Bélik, Olivier Denis, Pierre Bogaerts, Isabel Montesinos, Catherine Berhin, Warda Bouchahrouf, Martin Hoebeke, Stephanie Evrard, Nicolas Gilliard, Merve Okur, Te-Din Huang","doi":"10.1186/s12941-024-00708-0","DOIUrl":"https://doi.org/10.1186/s12941-024-00708-0","url":null,"abstract":"Aztreonam-avibactam (ATM-AVI) combination shows promising effectiveness on most carbapenemase-producing Gram-negatives, yet standardized antibiotic susceptibility testing (AST) methods for evaluating the combination in clinical laboratories is lacking. We aimed to evaluate different ATM-AVI AST approaches. 96 characterized carbapenem-resistant clinical isolates belonging to 9 Enterobacterales (EB; n = 80) and P. aeruginosa (PA; n = 16) species, including 90 carbapenemase producers and 72 strains resistant to both CAZ-AVI and ATM, were tested. Paper disk elution (DE; Bio-Rad) and E-test gradient strips stacking (SS; bioMérieux) were performed for the ATM + CAZ-AVI combination. MIC Test Strip (MTS; Liofilchem) was evaluated for ATM-AVI MIC determination. Results were interpreted applying ATM clinical breakpoints of the EUCAST guidelines and compared to the broth microdilution method (Sensititre, Thermofisher). According to broth microdilution method, 93% of EB and 69% of PA were tested susceptible to ATM-AVI. The synergistic effect of ATM-AVI was of 95% for EB, but of only 17% for PA. The MTS method yielded higher categorical and essential agreement (CA/EA) rates for both EB (89%/91%) and PA (94%/94%) compared to SS, where the rates were 87%/83% for EB and 81%/81% for PA. MTS and SS yielded 2 and 3 major discrepancies, respectively, while 3 very major discrepancies each were observed for both methods. Concerning the DE method, CA reached 91% for EB and 81% for PA, but high number of very major discrepancies were observed for EB (n = 6; 8%) and for PA (n = 3; 19%). The ATM-AVI association displayed excellent in vitro activity against highly resistant clinical Enterobacterales strains. MTS method offers accurate ATM-AVI AST results, while the SS method might serve as better alternative then DE method in assessing the efficacy of ATM + CAZ-AVI combination. However, further investigation is needed to confirm the methods' ability to detect ATM-AVI resistance.","PeriodicalId":8052,"journal":{"name":"Annals of Clinical Microbiology and Antimicrobials","volume":"34 1","pages":""},"PeriodicalIF":5.7,"publicationDate":"2024-05-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141152276","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Emergence of extensive drug resistance and high prevalence of multidrug resistance among clinical Proteus mirabilis isolates in Egypt. 埃及奇异变形杆菌临床分离株中出现广泛耐药性和多重耐药性的高流行率。
IF 5.7 2区 医学 Q1 MICROBIOLOGY Pub Date : 2024-05-24 DOI: 10.1186/s12941-024-00705-3
Maggi ElTaweel, Heba Shehta Said, Rasha Barwa

Background: Proteus mirabilis is an opportunistic pathogen that has been held responsible for numerous nosocomial and community-acquired infections which are difficult to be controlled because of its diverse antimicrobial resistance mechanisms.

Methods: Antimicrobial susceptibility patterns of P. mirabilis isolates collected from different clinical sources in Mansoura University Hospitals, Egypt was determined. Moreover, the underlying resistance mechanisms and genetic relatedness between isolates were investigated.

Results: Antimicrobial susceptibility testing indicated elevated levels of resistance to different classes of antimicrobials among the tested P. mirabilis clinical isolates (n = 66). ERIC-PCR showed great diversity among the tested isolates. Six isolates (9.1%) were XDR while all the remaining isolates were MDR. ESBLs and AmpCs were detected in 57.6% and 21.2% of the isolates, respectively, where blaTEM, blaSHV, blaCTX-M, blaCIT-M and blaAmpC were detected. Carbapenemases and MBLs were detected in 10.6 and 9.1% of the isolates, respectively, where blaOXA-48 and blaNDM-1 genes were detected. Quinolone resistant isolates (75.8%) harbored acc(6')-Ib-cr, qnrD, qnrA, and qnrS genes. Resistance to aminoglycosides, trimethoprim-sulfamethoxazole and chloramphenicol exceeded 80%. Fosfomycin was the most active drug against the tested isolates as only 22.7% were resistant. Class I or II integrons were detected in 86.4% of the isolates. Among class I integron positive isolates, four different gene cassette arrays (dfrA17- aadA5, aadB-aadA2, aadA2-lnuF, and dfrA14-arr-3-blaOXA-10-aadA15) and two gene cassettes (dfrA7 and aadA1) were detected. While class II integron positive isolates carried four different gene cassette arrays (dfrA1-sat1-aadA1, estXVr-sat2-aadA1, lnuF- dfrA1-aadA1, and dfrA1-sat2).

Conclusion: P. Mirabilis ability to acquire resistance determinants via integrons may be held responsible for the elevated rates of antimicrobial resistance and emergence of XDR or even PDR strains limiting the available therapeutic options for management of infections caused by those strains.

背景:mirabilis 变形杆菌是一种机会性病原体,是众多医院内感染和社区获得性感染的罪魁祸首,由于其具有多种抗菌药耐药机制而难以控制:方法:对从埃及曼苏拉大学医院不同临床来源采集的P. mirabilis分离株的抗菌药敏感性模式进行了测定。此外,还调查了分离株之间的潜在耐药机制和遗传相关性:结果:抗菌药敏感性测试表明,受测的奇异变形杆菌临床分离株(n = 66)对不同类别抗菌药的耐药性水平较高。ERIC-PCR显示受测分离株之间存在很大的多样性。有 6 个分离株(9.1%)具有 XDR,而其余所有分离株都具有 MDR。分别有 57.6% 和 21.2% 的分离物检测到 ESBLs 和 AmpCs,其中检测到 blaTEM、blaSHV、blaCTX-M、blaCIT-M 和 blaAmpC。在检测到 blaOXA-48 和 blaNDM-1 基因的分离物中,分别有 10.6% 和 9.1% 检测到碳青霉烯酶和 MBL。喹诺酮耐药分离物(75.8%)携带 acc(6')-Ib-cr、qnrD、qnrA 和 qnrS 基因。对氨基糖苷类、三甲双氨-磺胺甲噁唑和氯霉素的耐药性超过 80%。磷霉素是对测试分离株最有效的药物,只有 22.7% 的分离株对其产生耐药性。在 86.4% 的分离株中检测到了 I 类或 II 类整合子。在 I 类整合素阳性的分离物中,检测到了四个不同的基因盒阵列(dfrA17- aadA5、aadB-aadA2、aadA2-lnuF 和 dfrA14-arr-3-blaOXA-10-aadA15)和两个基因盒(dfrA7 和 aadA1)。而 II 类整合素阳性分离物携带有 4 个不同的基因盒阵列(dfrA1-sat1-aadA1、estXVr-sat2-aadA1、lnuF- dfrA1-aadA1 和 dfrA1-sat2):结论:P. Mirabilis通过整合子获得抗药性决定因子的能力可能是抗菌药耐药率升高和XDR甚至PDR菌株出现的原因,这限制了治疗由这些菌株引起的感染的可用疗法。
{"title":"Emergence of extensive drug resistance and high prevalence of multidrug resistance among clinical Proteus mirabilis isolates in Egypt.","authors":"Maggi ElTaweel, Heba Shehta Said, Rasha Barwa","doi":"10.1186/s12941-024-00705-3","DOIUrl":"10.1186/s12941-024-00705-3","url":null,"abstract":"<p><strong>Background: </strong>Proteus mirabilis is an opportunistic pathogen that has been held responsible for numerous nosocomial and community-acquired infections which are difficult to be controlled because of its diverse antimicrobial resistance mechanisms.</p><p><strong>Methods: </strong>Antimicrobial susceptibility patterns of P. mirabilis isolates collected from different clinical sources in Mansoura University Hospitals, Egypt was determined. Moreover, the underlying resistance mechanisms and genetic relatedness between isolates were investigated.</p><p><strong>Results: </strong>Antimicrobial susceptibility testing indicated elevated levels of resistance to different classes of antimicrobials among the tested P. mirabilis clinical isolates (n = 66). ERIC-PCR showed great diversity among the tested isolates. Six isolates (9.1%) were XDR while all the remaining isolates were MDR. ESBLs and AmpCs were detected in 57.6% and 21.2% of the isolates, respectively, where bla<sub>TEM</sub>, bla<sub>SHV</sub>, bla<sub>CTX-M</sub>, bla<sub>CIT-M</sub> and bla<sub>AmpC</sub> were detected. Carbapenemases and MBLs were detected in 10.6 and 9.1% of the isolates, respectively, where bla<sub>OXA-48</sub> and bla<sub>NDM-1</sub> genes were detected. Quinolone resistant isolates (75.8%) harbored acc(6')-Ib-cr, qnrD, qnrA, and qnrS genes. Resistance to aminoglycosides, trimethoprim-sulfamethoxazole and chloramphenicol exceeded 80%. Fosfomycin was the most active drug against the tested isolates as only 22.7% were resistant. Class I or II integrons were detected in 86.4% of the isolates. Among class I integron positive isolates, four different gene cassette arrays (dfrA17- aadA5, aadB-aadA2, aadA2-lnuF, and dfrA14-arr-3-bla<sub>OXA-10</sub>-aadA15) and two gene cassettes (dfrA7 and aadA1) were detected. While class II integron positive isolates carried four different gene cassette arrays (dfrA1-sat1-aadA1, estXVr-sat2-aadA1, lnuF- dfrA1-aadA1, and dfrA1-sat2).</p><p><strong>Conclusion: </strong>P. Mirabilis ability to acquire resistance determinants via integrons may be held responsible for the elevated rates of antimicrobial resistance and emergence of XDR or even PDR strains limiting the available therapeutic options for management of infections caused by those strains.</p>","PeriodicalId":8052,"journal":{"name":"Annals of Clinical Microbiology and Antimicrobials","volume":"23 1","pages":"46"},"PeriodicalIF":5.7,"publicationDate":"2024-05-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11127457/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141092462","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Phenotypic and genotypic analysis of antimicrobial resistance and population structure of gastroenteritis-related Aeromonas isolates. 对与肠胃炎相关的气单胞菌分离物的抗菌药耐药性和种群结构进行表型和基因型分析。
IF 5.7 2区 医学 Q1 MICROBIOLOGY Pub Date : 2024-05-23 DOI: 10.1186/s12941-024-00706-2
Dana Sagas, Yizhak Hershko, Katia Levitskyi, Merav Strauss, Matan Slutzkin, Bibiana Chazan, Amos Adler

Background: The population structure and the correlation between antimicrobial resistance (AMR) phenotypes and genotypes in Aeromonas species isolated from patients with gastroenteritis are not well understood. The aims of the study were to: (1) investigate the antimicrobial susceptibility profiles of Aeromonas species isolated from patients with gastroenteritis; (2) explore the relationship between AMR genes and resistance phenotypes; and (3) describe the population structure of these isolates and provide evidence of transmission events among them.

Methods: This microbiological survey was performed at the Microbiology Laboratory of the Emek Medical Center in Afula, Israel. Cultivation of Aeromonas was attempted from stool samples that tested positive by PCR. Antimicrobial susceptibility testing (AST) was performed using the Sensititre GN3F microdilution panel. Whole genome sequencing (WGS) was done using the Illumina NextSeq500/550 system. Phylogenetic studies involved multi-locus sequence typing (MLST) and core genome (cg) MLST. Resistance mechanisms were identified using the Comprehensive Antibiotic Resistance Database and compared with the AST results.

Results: The study included 67 patient-unique isolates. The species that were identified included A. caviae (n = 58), A. dhakensis (n = 3), A. media (n = 2), A. veronii (n = 2) and A. hydrophila (n = 2). Isolates were almost uniformly susceptible to amikacin, gentamicin, aztreonam, cefepime, ceftazidime, ciprofloxacin and meropenem. All isolates with the exception of 1-2 isolates were resistant to ampicillin, cefazolin and ampicillin-sulbactam which was compatible with the presence of the blaOXA genes. Variable resistance rates were observed to cefuroxime, cefoxitin, ceftriaxone, piperacillin-tazobactam that were not correlated with the presence of other β-lactamase genes. Resistance to tetracycline and trimethoprim-sulfamethoxazole correlated with the presence of tetA and sul1, respectively. The population structure of A. caviae was highly diverse with the minority of the isolates (16/57) clustering into six defined sequence types. A cgMLST-based distance of four genes was found in one pair of isolates, suggesting common source transmission.

Conclusions: A. caviae is the dominant species related to gastroenteritis and is characterized by a diverse population structure, with almost no evidence for common-source transmission. Resistance rates to most antimicrobial agents were low and partially matched with the presence of resistance genes.

背景:从肠胃炎患者体内分离出的气单胞菌的种群结构以及抗菌药耐药性(AMR)表型和基因型之间的相关性尚不十分清楚。本研究旨在(1) 调查从肠胃炎患者体内分离出的气单胞菌的抗菌药敏感性特征;(2) 探讨 AMR 基因与耐药性表型之间的关系;(3) 描述这些分离株的种群结构,并提供它们之间传播事件的证据:这项微生物学调查在以色列阿富拉埃梅克医疗中心的微生物实验室进行。尝试从 PCR 检测呈阳性的粪便样本中培养气单胞菌。使用 Sensititre GN3F 微稀释板进行了抗菌药物敏感性测试 (AST)。使用 Illumina NextSeq500/550 系统进行了全基因组测序(WGS)。系统发育研究包括多焦点序列分型(MLST)和核心基因组(cg)MLST。利用抗生素耐药性综合数据库确定耐药性机制,并与 AST 结果进行比较:研究包括 67 个病人独特的分离株。结果:该研究包括 67 个患者特有的分离菌株,鉴定出的菌种包括:A. caviae(n = 58)、A. dhakensis(n = 3)、A. media(n = 2)、A. veronii(n = 2)和 A. hydrophila(n = 2)。分离菌株对阿米卡星、庆大霉素、阿曲南、头孢吡肟、头孢他啶、环丙沙星和美罗培南几乎一致敏感。除 1-2 个分离株外,所有分离株都对氨苄西林、头孢唑啉和氨苄西林-舒巴坦有耐药性,这与 blaOXA 基因的存在相符。对头孢呋辛、头孢西丁、头孢曲松、哌拉西林-他唑巴坦的耐药率不尽相同,这与存在其他β-内酰胺酶基因无关。对四环素和三甲氧苄嘧啶-磺胺甲噁唑的抗药性分别与 tetA 和 sul1 的存在有关。鱼腥酵母菌的种群结构具有高度多样性,少数分离株(16/57)可分为六种明确的序列类型。在一对分离物中发现了基于 cgMLST 的四个基因的距离,这表明它们具有共同的传播源:结论:腔肠动物是与肠胃炎相关的主要物种,其种群结构多样,几乎没有共同来源传播的证据。对大多数抗菌药物的耐药率较低,且部分与耐药基因的存在相匹配。
{"title":"Phenotypic and genotypic analysis of antimicrobial resistance and population structure of gastroenteritis-related Aeromonas isolates.","authors":"Dana Sagas, Yizhak Hershko, Katia Levitskyi, Merav Strauss, Matan Slutzkin, Bibiana Chazan, Amos Adler","doi":"10.1186/s12941-024-00706-2","DOIUrl":"10.1186/s12941-024-00706-2","url":null,"abstract":"<p><strong>Background: </strong>The population structure and the correlation between antimicrobial resistance (AMR) phenotypes and genotypes in Aeromonas species isolated from patients with gastroenteritis are not well understood. The aims of the study were to: (1) investigate the antimicrobial susceptibility profiles of Aeromonas species isolated from patients with gastroenteritis; (2) explore the relationship between AMR genes and resistance phenotypes; and (3) describe the population structure of these isolates and provide evidence of transmission events among them.</p><p><strong>Methods: </strong>This microbiological survey was performed at the Microbiology Laboratory of the Emek Medical Center in Afula, Israel. Cultivation of Aeromonas was attempted from stool samples that tested positive by PCR. Antimicrobial susceptibility testing (AST) was performed using the Sensititre GN3F microdilution panel. Whole genome sequencing (WGS) was done using the Illumina NextSeq500/550 system. Phylogenetic studies involved multi-locus sequence typing (MLST) and core genome (cg) MLST. Resistance mechanisms were identified using the Comprehensive Antibiotic Resistance Database and compared with the AST results.</p><p><strong>Results: </strong>The study included 67 patient-unique isolates. The species that were identified included A. caviae (n = 58), A. dhakensis (n = 3), A. media (n = 2), A. veronii (n = 2) and A. hydrophila (n = 2). Isolates were almost uniformly susceptible to amikacin, gentamicin, aztreonam, cefepime, ceftazidime, ciprofloxacin and meropenem. All isolates with the exception of 1-2 isolates were resistant to ampicillin, cefazolin and ampicillin-sulbactam which was compatible with the presence of the bla<sub>OXA</sub> genes. Variable resistance rates were observed to cefuroxime, cefoxitin, ceftriaxone, piperacillin-tazobactam that were not correlated with the presence of other β-lactamase genes. Resistance to tetracycline and trimethoprim-sulfamethoxazole correlated with the presence of tetA and sul1, respectively. The population structure of A. caviae was highly diverse with the minority of the isolates (16/57) clustering into six defined sequence types. A cgMLST-based distance of four genes was found in one pair of isolates, suggesting common source transmission.</p><p><strong>Conclusions: </strong>A. caviae is the dominant species related to gastroenteritis and is characterized by a diverse population structure, with almost no evidence for common-source transmission. Resistance rates to most antimicrobial agents were low and partially matched with the presence of resistance genes.</p>","PeriodicalId":8052,"journal":{"name":"Annals of Clinical Microbiology and Antimicrobials","volume":"23 1","pages":"45"},"PeriodicalIF":5.7,"publicationDate":"2024-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11119697/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141086437","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dual-function antimicrobial-antibiofilm peptide hybrid to tackle biofilm-forming Staphylococcus epidermidis. 双功能抗菌-抗生物膜肽混合物,用于对付形成生物膜的表皮葡萄球菌。
IF 5.7 2区 医学 Q1 MICROBIOLOGY Pub Date : 2024-05-16 DOI: 10.1186/s12941-024-00701-7
Mathira Wongchai, Saharut Wongkaewkhiaw, Sakawrat Kanthawong, Sittiruk Roytrakul, Ratchaneewan Aunpad
<p><strong>Background: </strong>Due to their resistance and difficulty in treatment, biofilm-associated infections are problematic among hospitalized patients globally and account for 60% of all bacterial infections in humans. Antibiofilm peptides have recently emerged as an alternative treatment since they can be effectively designed and exert a different mode of biofilm inhibition and eradication.</p><p><strong>Methods: </strong>A novel antibiofilm peptide, BiF, was designed from the conserved sequence of 18 α-helical antibiofilm peptides by template-assisted technique and its activity was improved by hybridization with a lipid binding motif (KILRR). Novel antibiofilm peptide derivatives were modified by substituting hydrophobic amino acids at positions 5 or 7, and both, with positively charged lysines (L5K, L7K). These peptide derivatives were tested for antibiofilm and antimicrobial activities against biofilm-forming Staphylococcus epidermidis and multiple other microbes using crystal violet and broth microdilution assays, respectively. To assess their impact on mammalian cells, the toxicity of peptides was determined through hemolysis and cytotoxicity assays. The stability of candidate peptide, BiF2_5K7K, was assessed in human serum and its secondary structure in bacterial membrane-like environments was analyzed using circular dichroism. The action of BiF2_5K7K on planktonic S. epidermidis and its effect on biofilm cell viability were assessed via viable counting assays. Its biofilm inhibition mechanism was investigated through confocal laser scanning microscopy and transcription analysis. Additionally, its ability to eradicate mature biofilms was examined using colony counting. Finally, a preliminary evaluation involved coating a catheter with BiF2_5K7K to assess its preventive efficacy against S. epidermidis biofilm formation on the catheter and its surrounding area.</p><p><strong>Results: </strong>BiF2_5K7K, the modified antibiofilm peptide, exhibited dose-dependent antibiofilm activity against S. epidermidis. It inhibited biofilm formation at subinhibitory concentrations by altering S. epidermidis extracellular polysaccharide production and quorum-sensing gene expression. Additionally, it exhibited broad-spectrum antimicrobial activity and no significant hemolysis or toxicity against mammalian cell lines was observed. Its activity is retained when exposed to human serum. In bacterial membrane-like environments, this peptide formed an α-helix amphipathic structure. Within 4 h, a reduction in the number of S. epidermidis colonies was observed, demonstrating the fast action of this peptide. As a preliminary test, a BiF2_5K7K-coated catheter was able to prevent the development of S. epidermidis biofilm both on the catheter surface and in its surrounding area.</p><p><strong>Conclusions: </strong>Due to the safety and effectiveness of BiF2_5K7K, we suggest that this peptide be further developed to combat biofilm infections, particularly those
背景:由于生物膜的耐药性和治疗难度,生物膜相关感染是全球住院病人的一大难题,占人类所有细菌感染的60%。抗生物膜肽是最近出现的一种替代治疗方法,因为它们可以被有效设计,并以不同的模式抑制和根除生物膜:方法:利用模板辅助技术,从 18 种 α-helical 抗生物膜肽的保守序列中设计出一种新型抗生物膜肽 BiF,并通过与脂质结合基序(KILRR)杂交提高其活性。通过用带正电荷的赖氨酸(L5K、L7K)取代第 5 位或第 7 位以及这两个位置的疏水氨基酸,对新型抗生物膜肽衍生物进行了修饰。利用水晶紫法和肉汤微稀释法测试了这些肽衍生物对形成生物膜的表皮葡萄球菌和其他多种微生物的抗生物膜和抗菌活性。为了评估多肽对哺乳动物细胞的影响,还通过溶血和细胞毒性试验确定了多肽的毒性。评估了候选肽 BiF2_5K7K 在人血清中的稳定性,并利用圆二色性分析了其在细菌膜样环境中的二级结构。BiF2_5K7K 对浮游表皮葡萄球菌的作用及其对生物膜细胞活力的影响通过活力计数法进行了评估。通过共焦激光扫描显微镜和转录分析研究了其抑制生物膜的机制。此外,还使用菌落计数法检测了其根除成熟生物膜的能力。最后,在导管上涂上 BiF2_5K7K 进行了初步评估,以评估其对导管及其周围区域的表皮葡萄球菌生物膜形成的预防效果:结果:改良抗生物膜肽 BiF2_5K7K 对表皮葡萄球菌具有剂量依赖性抗生物膜活性。它通过改变表皮葡萄球菌胞外多糖的产生和法定量感应基因的表达,在亚抑制浓度下抑制生物膜的形成。此外,它还具有广谱抗菌活性,对哺乳动物细胞株没有明显的溶血或毒性。当暴露于人类血清中时,它的活性仍能保持。在类似细菌膜的环境中,这种肽形成了一种 α 螺旋两亲结构。在 4 小时内,观察到表皮葡萄球菌菌落数量减少,这证明了这种肽的快速作用。作为初步测试,涂有 BiF2_5K7K 的导管能够防止表皮葡萄球菌在导管表面及其周围形成生物膜:鉴于 BiF2_5K7K 的安全性和有效性,我们建议进一步开发这种多肽,以防治生物膜感染,尤其是由形成生物膜的表皮葡萄球菌引起的感染。
{"title":"Dual-function antimicrobial-antibiofilm peptide hybrid to tackle biofilm-forming Staphylococcus epidermidis.","authors":"Mathira Wongchai, Saharut Wongkaewkhiaw, Sakawrat Kanthawong, Sittiruk Roytrakul, Ratchaneewan Aunpad","doi":"10.1186/s12941-024-00701-7","DOIUrl":"https://doi.org/10.1186/s12941-024-00701-7","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Due to their resistance and difficulty in treatment, biofilm-associated infections are problematic among hospitalized patients globally and account for 60% of all bacterial infections in humans. Antibiofilm peptides have recently emerged as an alternative treatment since they can be effectively designed and exert a different mode of biofilm inhibition and eradication.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;A novel antibiofilm peptide, BiF, was designed from the conserved sequence of 18 α-helical antibiofilm peptides by template-assisted technique and its activity was improved by hybridization with a lipid binding motif (KILRR). Novel antibiofilm peptide derivatives were modified by substituting hydrophobic amino acids at positions 5 or 7, and both, with positively charged lysines (L5K, L7K). These peptide derivatives were tested for antibiofilm and antimicrobial activities against biofilm-forming Staphylococcus epidermidis and multiple other microbes using crystal violet and broth microdilution assays, respectively. To assess their impact on mammalian cells, the toxicity of peptides was determined through hemolysis and cytotoxicity assays. The stability of candidate peptide, BiF2_5K7K, was assessed in human serum and its secondary structure in bacterial membrane-like environments was analyzed using circular dichroism. The action of BiF2_5K7K on planktonic S. epidermidis and its effect on biofilm cell viability were assessed via viable counting assays. Its biofilm inhibition mechanism was investigated through confocal laser scanning microscopy and transcription analysis. Additionally, its ability to eradicate mature biofilms was examined using colony counting. Finally, a preliminary evaluation involved coating a catheter with BiF2_5K7K to assess its preventive efficacy against S. epidermidis biofilm formation on the catheter and its surrounding area.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;BiF2_5K7K, the modified antibiofilm peptide, exhibited dose-dependent antibiofilm activity against S. epidermidis. It inhibited biofilm formation at subinhibitory concentrations by altering S. epidermidis extracellular polysaccharide production and quorum-sensing gene expression. Additionally, it exhibited broad-spectrum antimicrobial activity and no significant hemolysis or toxicity against mammalian cell lines was observed. Its activity is retained when exposed to human serum. In bacterial membrane-like environments, this peptide formed an α-helix amphipathic structure. Within 4 h, a reduction in the number of S. epidermidis colonies was observed, demonstrating the fast action of this peptide. As a preliminary test, a BiF2_5K7K-coated catheter was able to prevent the development of S. epidermidis biofilm both on the catheter surface and in its surrounding area.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;Due to the safety and effectiveness of BiF2_5K7K, we suggest that this peptide be further developed to combat biofilm infections, particularly those ","PeriodicalId":8052,"journal":{"name":"Annals of Clinical Microbiology and Antimicrobials","volume":"23 1","pages":"44"},"PeriodicalIF":5.7,"publicationDate":"2024-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11100219/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140955914","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Left knee septic monoarthritis in a pediatric patient due to shewanella putrefaciens: case report and literature review. 一名儿童患者的左膝化脓性单关节炎是由腐生雪旺菌引起的:病例报告和文献综述。
IF 4.6 2区 医学 Q1 MICROBIOLOGY Pub Date : 2024-05-10 DOI: 10.1186/s12941-024-00702-6
Nathalie Yepes Madrid, Luis Fernando Mejia, José Fernando Gomez Urrego

Background: Shewanella putrefaciens is a gram-negative, nonfermenting, oxidase-positive, hydrogen sulfide-producing bacillus and a halophilic bacterium, known for causing unusual infections in humans and often regarded as an opportunistic pathogen. Its diverse symptoms have a significant impact on human health, with 260 documented disorders reported in the literature over the last 40 years, highlighting its potential danger.

Case presentation: We present the case of a previously healthy 15-year-old male patient who sustained a self-inflicted sharp-object injury while working in the field, resulting in secondary septic monoarthritis due to Shewanella putrefaciens.

Conclusions: This case highlights the bacteriological and clinical characteristics, as well as the antibiogram, of Shewanella spp. Given the recent increase in notifications of Shewanella infections, predominantly by S. algae and S. putrefaciens, it is essential to consider these pathogens in patients with a history of contact with bodies of water. Special attention must be paid to their resistance patterns in patient management to prevent the development of intrinsic antimicrobial resistance.

背景:普氏希瓦菌(Shewanella putrefaciens)是一种革兰氏阴性、不发酵、氧化酶阳性、产硫化氢的杆菌和嗜盐细菌,以引起人类异常感染而闻名,通常被视为机会性病原体。它的症状多种多样,对人类健康有重大影响,在过去的 40 年中,文献报道了 260 种病症,突显了其潜在的危险性:我们介绍的病例是一名原本健康的 15 岁男性患者,他在野外工作时不慎被锐器所伤,导致继发性化脓性单关节炎,病原体是腐生雪旺菌:本病例强调了雪旺菌属的细菌学和临床特征以及抗生素谱。鉴于最近雪旺菌感染(主要是藻雪旺菌和腐生雪旺菌)的病例增多,对于有水体接触史的患者,必须考虑这些病原体。在患者管理中必须特别注意这些病原体的耐药性模式,以防止产生内在的抗菌药耐药性。
{"title":"Left knee septic monoarthritis in a pediatric patient due to shewanella putrefaciens: case report and literature review.","authors":"Nathalie Yepes Madrid, Luis Fernando Mejia, José Fernando Gomez Urrego","doi":"10.1186/s12941-024-00702-6","DOIUrl":"10.1186/s12941-024-00702-6","url":null,"abstract":"<p><strong>Background: </strong>Shewanella putrefaciens is a gram-negative, nonfermenting, oxidase-positive, hydrogen sulfide-producing bacillus and a halophilic bacterium, known for causing unusual infections in humans and often regarded as an opportunistic pathogen. Its diverse symptoms have a significant impact on human health, with 260 documented disorders reported in the literature over the last 40 years, highlighting its potential danger.</p><p><strong>Case presentation: </strong>We present the case of a previously healthy 15-year-old male patient who sustained a self-inflicted sharp-object injury while working in the field, resulting in secondary septic monoarthritis due to Shewanella putrefaciens.</p><p><strong>Conclusions: </strong>This case highlights the bacteriological and clinical characteristics, as well as the antibiogram, of Shewanella spp. Given the recent increase in notifications of Shewanella infections, predominantly by S. algae and S. putrefaciens, it is essential to consider these pathogens in patients with a history of contact with bodies of water. Special attention must be paid to their resistance patterns in patient management to prevent the development of intrinsic antimicrobial resistance.</p>","PeriodicalId":8052,"journal":{"name":"Annals of Clinical Microbiology and Antimicrobials","volume":"23 1","pages":"43"},"PeriodicalIF":4.6,"publicationDate":"2024-05-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11088002/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140904025","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Differences in clinical outcomes of bloodstream infections caused by Klebsiella aerogenes, Klebsiella pneumoniae and Enterobacter cloacae: a multicentre cohort study. 产气克雷伯菌、肺炎克雷伯菌和泄殖腔肠杆菌引起的血流感染的临床结果差异:一项多中心队列研究。
IF 5.7 2区 医学 Q1 MICROBIOLOGY Pub Date : 2024-05-06 DOI: 10.1186/s12941-024-00700-8
Mariana Guedes, David Gathara, Inmaculada López-Hernández, Pedro María Martínez Pérez-Crespo, María Teresa Pérez-Rodríguez, Adrian Sousa, Antonio Plata, Jose María Reguera-Iglesias, Lucía Boix-Palop, Beatriz Dietl, Juan Sevilla Blanco, Carlos Armiñanzas Castillo, Fátima Galán-Sánchez, Clara Natera Kindelán, Alfredo Jover-Saenz, Josune Goikoetxea Aguirre, Ana Alemán Alemán, Teresa Marrodán Ciordia, Alfonso Del Arco Jiménez, Jonathan Fernandez-Suarez, Luis Eduardo Lopez-Cortes, Jesús Rodríguez-Baño

Background: Klebsiella aerogenes has been reclassified from Enterobacter to Klebsiella genus due to its phenotypic and genotypic similarities with Klebsiella pneumoniae. It is unclear if clinical outcomes are also more similar. This study aims to assess clinical outcomes of bloodstreams infections (BSI) caused by K. aerogenes, K. pneumoniae and Enterobacter cloacae, through secondary data analysis, nested in PRO-BAC cohort study.

Methods: Hospitalized patients between October 2016 and March 2017 with monomicrobial BSI due to K. aerogenes, K. pneumoniae or E. cloacae were included. Primary outcome was a composite clinical outcome including all-cause mortality or recurrence until 30 days follow-up. Secondary outcomes were fever ≥ 72 h, persistent bacteraemia, and secondary device infection. Multilevel mixed-effect Poisson regression was used to estimate the association between microorganisms and outcome.

Results: Overall, 29 K. aerogenes, 77 E. cloacae and 337 K. pneumoniae BSI episodes were included. Mortality or recurrence was less frequent in K. aerogenes (6.9%) than in E. cloacae (20.8%) or K. pneumoniae (19.0%), but statistical difference was not observed (rate ratio (RR) 0.35, 95% CI 0.08 to 1.55; RR 0.42, 95% CI 0.10 to 1.71, respectively). Fever ≥ 72 h and device infection were more common in K. aerogenes group. In the multivariate analysis, adjusted for confounders (age, sex, BSI source, hospital ward, Charlson score and active antibiotic therapy), the estimates and direction of effect were similar to crude results.

Conclusions: Results suggest that BSI caused by K. aerogenes may have a better prognosis than E. cloacae or K. pneumoniae BSI.

背景:由于其表型和基因型与肺炎克雷伯菌相似,产气克雷伯菌已从肠杆菌属重新分类为克雷伯菌属。目前尚不清楚临床结果是否也更为相似。本研究旨在通过二级数据分析,嵌套于PRO-BAC队列研究,评估产气荚膜克雷伯菌、肺炎克雷伯菌和泄殖腔肠杆菌引起的血流感染(BSI)的临床结局。方法:纳入2016年10月至2017年3月期间因产气荚膜克雷伯菌、肺炎克雷伯菌或泄殖腔肠杆菌引起单微生物BSI的住院患者。主要结果为综合临床结果,包括全因死亡率或随访30天前的复发率。次要结果为发热≥72小时、持续菌血症和二次设备感染。多层次混合效应泊松回归用于估计微生物与结果之间的关联:结果:总共纳入了 29 例产气荚膜杆菌、77 例衣霉菌和 337 例肺炎双球菌 BSI 病例。与丁香杆菌(20.8%)或肺炎双球菌(19.0%)相比,产气荚膜杆菌(6.9%)的死亡率或复发率较低,但未观察到统计学差异(比率比(RR)分别为 0.35,95% CI 0.08 至 1.55;RR 0.42,95% CI 0.10 至 1.71)。在产气荚膜杆菌组中,发热≥72 h和器械感染更为常见。在对混杂因素(年龄、性别、BSI来源、病房、Charlson评分和积极抗生素治疗)进行调整后的多变量分析中,估计值和效应方向与粗略结果相似:结果表明,与丁香杆菌或肺炎双球菌引起的BSI相比,产气荚膜杆菌引起的BSI预后可能更好。
{"title":"Differences in clinical outcomes of bloodstream infections caused by Klebsiella aerogenes, Klebsiella pneumoniae and Enterobacter cloacae: a multicentre cohort study.","authors":"Mariana Guedes, David Gathara, Inmaculada López-Hernández, Pedro María Martínez Pérez-Crespo, María Teresa Pérez-Rodríguez, Adrian Sousa, Antonio Plata, Jose María Reguera-Iglesias, Lucía Boix-Palop, Beatriz Dietl, Juan Sevilla Blanco, Carlos Armiñanzas Castillo, Fátima Galán-Sánchez, Clara Natera Kindelán, Alfredo Jover-Saenz, Josune Goikoetxea Aguirre, Ana Alemán Alemán, Teresa Marrodán Ciordia, Alfonso Del Arco Jiménez, Jonathan Fernandez-Suarez, Luis Eduardo Lopez-Cortes, Jesús Rodríguez-Baño","doi":"10.1186/s12941-024-00700-8","DOIUrl":"10.1186/s12941-024-00700-8","url":null,"abstract":"<p><strong>Background: </strong>Klebsiella aerogenes has been reclassified from Enterobacter to Klebsiella genus due to its phenotypic and genotypic similarities with Klebsiella pneumoniae. It is unclear if clinical outcomes are also more similar. This study aims to assess clinical outcomes of bloodstreams infections (BSI) caused by K. aerogenes, K. pneumoniae and Enterobacter cloacae, through secondary data analysis, nested in PRO-BAC cohort study.</p><p><strong>Methods: </strong>Hospitalized patients between October 2016 and March 2017 with monomicrobial BSI due to K. aerogenes, K. pneumoniae or E. cloacae were included. Primary outcome was a composite clinical outcome including all-cause mortality or recurrence until 30 days follow-up. Secondary outcomes were fever ≥ 72 h, persistent bacteraemia, and secondary device infection. Multilevel mixed-effect Poisson regression was used to estimate the association between microorganisms and outcome.</p><p><strong>Results: </strong>Overall, 29 K. aerogenes, 77 E. cloacae and 337 K. pneumoniae BSI episodes were included. Mortality or recurrence was less frequent in K. aerogenes (6.9%) than in E. cloacae (20.8%) or K. pneumoniae (19.0%), but statistical difference was not observed (rate ratio (RR) 0.35, 95% CI 0.08 to 1.55; RR 0.42, 95% CI 0.10 to 1.71, respectively). Fever ≥ 72 h and device infection were more common in K. aerogenes group. In the multivariate analysis, adjusted for confounders (age, sex, BSI source, hospital ward, Charlson score and active antibiotic therapy), the estimates and direction of effect were similar to crude results.</p><p><strong>Conclusions: </strong>Results suggest that BSI caused by K. aerogenes may have a better prognosis than E. cloacae or K. pneumoniae BSI.</p>","PeriodicalId":8052,"journal":{"name":"Annals of Clinical Microbiology and Antimicrobials","volume":"23 1","pages":"42"},"PeriodicalIF":5.7,"publicationDate":"2024-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11071190/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140849588","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Genomic epidemiology reveals multiple mechanisms of linezolid resistance in clinical enterococci in China 基因组流行病学揭示中国临床肠球菌耐利奈唑胺的多重机制
IF 5.7 2区 医学 Q1 MICROBIOLOGY Pub Date : 2024-05-04 DOI: 10.1186/s12941-024-00689-0
Ziran Wang, Danping Liu, Jingjia Zhang, Lingli Liu, Zeming Zhang, Chang Liu, Songnian Hu, Linhuan Wu, Zilong He, Hongli Sun
Infections caused by linezolid-resistant enterococci (LRE) are clinically difficult to treat and threaten patient health. However, there is a lack of studies on long time-span LRE strains in China. For this reason, our study comprehensively revealed the resistance mechanisms of LRE strains collected in a Chinese tertiary care hospital from 2011 to 2022. Enterococcal strains were screened and verified after retrospective analysis of microbial data. Subsequently, 65 LRE strains (61 Enterococcus faecalis and 4 Enterococcus faecium, MIC ≥ 8 µg/ml), 1 linezolid-intermediate Enterococcus faecium (MIC = 4 µg/ml) and 1 linezolid-susceptible Enterococcus faecium (MIC = 1.5 µg/ml) were submitted for whole-genome sequencing (WGS) analysis and bioinformatics analysis. The optrA gene was found to be the most common linezolid resistance mechanism in our study. We identified the wild-type OptrA and various OptrA variants in 98.5% of LRE strains (61 Enterococcus faecalis and 3 Enterococcus faecium). We also found one linezolid-resistant Enterococcus faecium strain carried both optrA and cfr(D) gene, while one linezolid-resistant Enterococcus faecium only harbored the poxtA gene. Most optrA genes (55/64) were located on plasmids, with impB-fexA-optrA, impB-fexA-optrA-erm(A), fexA-optrA-erm(A), and fexA-optrA segments. A minority of optrA genes (9/64) were found on chromosomes with the Tn6674-like platform. Besides, other possible linezolid resistance-associated mechanisms (mutations in the rplC and rplD genes) were also found in 26 enterococcal strains. Our study suggested that multiple mechanisms of linezolid resistance exist among clinical LRE strains in China.
耐利奈唑胺肠球菌(LRE)引起的感染在临床上难以治疗,并威胁着患者的健康。然而,目前国内尚缺乏对长效耐利奈唑胺肠球菌菌株的研究。为此,我们的研究全面揭示了从2011年至2022年在一家中国三级甲等医院采集的耐药肠球菌菌株的耐药机制。在对微生物数据进行回顾性分析后,筛选并验证了肠球菌菌株。随后,对 65 株 LRE 菌株(61 株粪肠球菌和 4 株粪肠球菌,MIC ≥ 8 µg/ml)、1 株利奈唑胺中间型粪肠球菌(MIC = 4 µg/ml)和 1 株利奈唑胺敏感型粪肠球菌(MIC = 1.5 µg/ml)进行了全基因组测序(WGS)分析和生物信息学分析。在我们的研究中,发现 optrA 基因是最常见的利奈唑胺耐药机制。我们在 98.5% 的 LRE 菌株(61 株粪肠球菌和 3 株粪肠球菌)中发现了野生型 OptrA 和各种 OptrA 变体。我们还发现一株耐利奈唑胺的粪肠球菌同时携带 optrA 和 cfr(D) 基因,而一株耐利奈唑胺的粪肠球菌只携带 poxtA 基因。大多数 optrA 基因(55/64)位于质粒上,有 impB-fexA-optrA、impB-fexA-optrA-erm(A)、fexA-optrA-erm(A) 和 fexA-optrA 片段。在具有类似 Tn6674 平台的染色体上发现了少数 optrA 基因(9/64)。此外,在 26 株肠球菌中还发现了其他可能的利奈唑胺耐药性相关机制(rplC 和 rplD 基因突变)。我们的研究表明,在中国的临床 LRE 菌株中存在多种利奈唑胺耐药机制。
{"title":"Genomic epidemiology reveals multiple mechanisms of linezolid resistance in clinical enterococci in China","authors":"Ziran Wang, Danping Liu, Jingjia Zhang, Lingli Liu, Zeming Zhang, Chang Liu, Songnian Hu, Linhuan Wu, Zilong He, Hongli Sun","doi":"10.1186/s12941-024-00689-0","DOIUrl":"https://doi.org/10.1186/s12941-024-00689-0","url":null,"abstract":"Infections caused by linezolid-resistant enterococci (LRE) are clinically difficult to treat and threaten patient health. However, there is a lack of studies on long time-span LRE strains in China. For this reason, our study comprehensively revealed the resistance mechanisms of LRE strains collected in a Chinese tertiary care hospital from 2011 to 2022. Enterococcal strains were screened and verified after retrospective analysis of microbial data. Subsequently, 65 LRE strains (61 Enterococcus faecalis and 4 Enterococcus faecium, MIC ≥ 8 µg/ml), 1 linezolid-intermediate Enterococcus faecium (MIC = 4 µg/ml) and 1 linezolid-susceptible Enterococcus faecium (MIC = 1.5 µg/ml) were submitted for whole-genome sequencing (WGS) analysis and bioinformatics analysis. The optrA gene was found to be the most common linezolid resistance mechanism in our study. We identified the wild-type OptrA and various OptrA variants in 98.5% of LRE strains (61 Enterococcus faecalis and 3 Enterococcus faecium). We also found one linezolid-resistant Enterococcus faecium strain carried both optrA and cfr(D) gene, while one linezolid-resistant Enterococcus faecium only harbored the poxtA gene. Most optrA genes (55/64) were located on plasmids, with impB-fexA-optrA, impB-fexA-optrA-erm(A), fexA-optrA-erm(A), and fexA-optrA segments. A minority of optrA genes (9/64) were found on chromosomes with the Tn6674-like platform. Besides, other possible linezolid resistance-associated mechanisms (mutations in the rplC and rplD genes) were also found in 26 enterococcal strains. Our study suggested that multiple mechanisms of linezolid resistance exist among clinical LRE strains in China.","PeriodicalId":8052,"journal":{"name":"Annals of Clinical Microbiology and Antimicrobials","volume":"13 1","pages":""},"PeriodicalIF":5.7,"publicationDate":"2024-05-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140839381","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence and genetic basis of Mycobacterium tuberculosis resistance to pretomanid in China 中国结核分枝杆菌对普托玛尼耐药性的流行和遗传基础
IF 5.7 2区 医学 Q1 MICROBIOLOGY Pub Date : 2024-05-03 DOI: 10.1186/s12941-024-00697-0
Bing Zhao, Huiwen Zheng, Juliano Timm, Zexuan Song, Shaojun Pei, Ruida Xing, Yajie Guo, Ling Ma, Feina Li, Qing Li, Yan Li, Lin Huang, Chong Teng, Ni Wang, Aastha Gupta, Sandeep Juneja, Fei Huang, Yanlin Zhao, Xichao Ou
Pretomanid is a key component of new regimens for the treatment of drug-resistant tuberculosis (TB) which are being rolled out globally. However, there is limited information on the prevalence of pre-existing resistance to the drug. To investigate pretomanid resistance rates in China and its underlying genetic basis, as well as to generate additional minimum inhibitory concentration (MIC) data for epidemiological cutoff (ECOFF)/breakpoint setting, we performed MIC determinations in the Mycobacterial Growth Indicator Tube™ (MGIT) system, followed by WGS analysis, on 475 Mycobacterium tuberculosis (MTB) isolated from Chinese TB patients between 2013 and 2020. We observed a pretomanid MIC distribution with a 99% ECOFF equal to 0.5 mg/L. Of the 15 isolates with MIC values > 0.5 mg/L, one (MIC = 1 mg/L) was identified as MTB lineage 1 (L1), a genotype previously reported to be intrinsically less susceptible to pretomanid, two were borderline resistant (MIC = 2–4 mg/L) and the remaining 12 isolates were highly resistant (MIC ≥ 16 mg/L) to the drug. Five resistant isolates did not harbor mutations in the known pretomanid resistant genes. Our results further support a breakpoint of 0.5 mg/L for a non-L1 MTB population, which is characteristic of China. Further, our data point to an unexpected high (14/475, 3%) pre-existing pretomanid resistance rate in the country, as well as to the existence of yet-to-be-discovered pretomanid resistance genes.
普利托马尼是治疗耐药性结核病(TB)的新方案的关键组成部分,该方案正在全球范围内推广。然而,有关该药物原有耐药性的信息却十分有限。为了调查中国的前马尼肽耐药率及其潜在的遗传基础,并为流行病学截断点(ECOFF)/爆发点的设定提供更多的最低抑菌浓度(MIC)数据,我们在分枝杆菌生长指示管™(MGIT)系统中对 2013 年至 2020 年间从中国肺结核患者中分离的 475 株结核分枝杆菌(MTB)进行了 MIC 测定,随后进行了 WGS 分析。我们观察到 MIC 值呈前芒硝分布,99% 的 ECOFF 值等于 0.5 mg/L。在MIC值大于0.5 mg/L的15个分离株中,有一个(MIC = 1 mg/L)被鉴定为MTB 1系(L1),该基因型先前被报道为对pretomanid的内在敏感性较低;两个为边缘耐药(MIC = 2-4 mg/L),其余12个分离株为高度耐药(MIC ≥ 16 mg/L)。五个耐药分离株没有携带已知的普托马尼耐药基因突变。我们的研究结果进一步支持了中国特有的非 L1 MTB 群体的断点为 0.5 mg/L。此外,我们的数据还表明,中国存在意想不到的高耐药率(14/475,3%)以及尚未发现的耐药基因。
{"title":"Prevalence and genetic basis of Mycobacterium tuberculosis resistance to pretomanid in China","authors":"Bing Zhao, Huiwen Zheng, Juliano Timm, Zexuan Song, Shaojun Pei, Ruida Xing, Yajie Guo, Ling Ma, Feina Li, Qing Li, Yan Li, Lin Huang, Chong Teng, Ni Wang, Aastha Gupta, Sandeep Juneja, Fei Huang, Yanlin Zhao, Xichao Ou","doi":"10.1186/s12941-024-00697-0","DOIUrl":"https://doi.org/10.1186/s12941-024-00697-0","url":null,"abstract":"Pretomanid is a key component of new regimens for the treatment of drug-resistant tuberculosis (TB) which are being rolled out globally. However, there is limited information on the prevalence of pre-existing resistance to the drug. To investigate pretomanid resistance rates in China and its underlying genetic basis, as well as to generate additional minimum inhibitory concentration (MIC) data for epidemiological cutoff (ECOFF)/breakpoint setting, we performed MIC determinations in the Mycobacterial Growth Indicator Tube™ (MGIT) system, followed by WGS analysis, on 475 Mycobacterium tuberculosis (MTB) isolated from Chinese TB patients between 2013 and 2020. We observed a pretomanid MIC distribution with a 99% ECOFF equal to 0.5 mg/L. Of the 15 isolates with MIC values > 0.5 mg/L, one (MIC = 1 mg/L) was identified as MTB lineage 1 (L1), a genotype previously reported to be intrinsically less susceptible to pretomanid, two were borderline resistant (MIC = 2–4 mg/L) and the remaining 12 isolates were highly resistant (MIC ≥ 16 mg/L) to the drug. Five resistant isolates did not harbor mutations in the known pretomanid resistant genes. Our results further support a breakpoint of 0.5 mg/L for a non-L1 MTB population, which is characteristic of China. Further, our data point to an unexpected high (14/475, 3%) pre-existing pretomanid resistance rate in the country, as well as to the existence of yet-to-be-discovered pretomanid resistance genes.","PeriodicalId":8052,"journal":{"name":"Annals of Clinical Microbiology and Antimicrobials","volume":"45 1","pages":""},"PeriodicalIF":5.7,"publicationDate":"2024-05-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140839385","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Annals of Clinical Microbiology and Antimicrobials
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1